IL-33 Enhances ACE2 Expression on Epidermal Keratinocytes in Atopic Dermatitis: A Plausible Issue for SARS-CoV-2 Transmission in Inflamed Atopic Skin
Background: Interleukin-33 (IL-33) is an important cytokine in the pathophysiology of atopic dermatitis (AD) and in the progression of COVID-19. Angiotensin converting enzyme 2 (ACE2), the entry receptor for SARS-CoV-2, is expressed in epidermal keratinocytes. Whether IL-33 could regulate the expres...
Main Authors: | En-Cheng Lin, Chien-Hui Hong |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-05-01
|
Series: | Biomedicines |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9059/10/5/1183 |
Similar Items
-
Serum levels and single nucleotide polymorphisms of the interleukin-33 gene in atopic dermatitis
by: Anna Zaryczańska, et al.
Published: (2022-03-01) -
The role of interleukin-1ß and interleukin-33 in atopic dermatitis
by: Rania M. Abdel Hay, et al.
Published: (2013-01-01) -
Regulatory Mechanism of the IL-33–IL-37 Axis via Aryl Hydrocarbon Receptor in Atopic Dermatitis and Psoriasis
by: Gaku Tsuji, et al.
Published: (2023-09-01) -
Microbiota and IL-33/31 Axis Linkage: Implications and Therapeutic Perspectives in Atopic Dermatitis and Psoriasis
by: Laura Bonzano, et al.
Published: (2023-07-01) -
Immunomodulatory Role of <i>Staphylococcus aureus</i> in Atopic Dermatitis
by: Ethan Jachen Chung, et al.
Published: (2022-03-01)